IP Library › Granted Patent US 6,908,902
Granted Patent B2
US 6,908,902 · App. 10/056,828 · Granted Jun 21, 2005

Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,908,902
App. No.
10/056,828
Granted
Jun 21, 2005
Kind
B2
Abstract

Co-therapy for the treatment of neurological dysfunctions comprising administration of one or more fructopyranose sulfamates and erythropoietin.

Claims (7)

1. A method for promoting neurite outgrowth in a subject, comprising administering an amount of topiramate and erythropoietin effective to promote the neurite outgrowth; wherein the amount of topiramate and the amount of erythropoietin are selected to produce a synergistic effect.

2. The method of claim 1 , wherein the amount of topiramate is from about 10 to 1000 mg.

3. The method of claim 1 , wherein the erythropoietin is epoetin alfa.

4. The method of claim 1 , wherein the amount of erythropoietin is from about 1 to 15000 I.U./kg.

5. The method of claim 1 , wherein said subject has epilepsy.

6. A pharmaceutical composition comprising topiramate, erythropoietin and a pharmaceutically acceptable carrier.

7. A process for making a pharmaceutical composition comprising mixing topiramate, erythropoietin and a pharmaceutically acceptable carrier.